Published in Otol Neurotol on August 01, 2013
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 1.90
Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res (2007) 1.87
Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J (2006) 1.25
The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle (2007) 1.11
Survivin's dual role: an export's view. Cell Cycle (2007) 1.07
Reanimation of the paralyzed human larynx with an implantable electrical stimulation device. Laryngoscope (2003) 1.02
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res (2008) 1.02
Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol (2004) 1.01
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int J Cancer (2009) 1.01
First-night-effect on polysomnographic respiratory sleep parameters in patients with sleep-disordered breathing and upper airway pathology. Eur Arch Otorhinolaryngol (2010) 0.94
Spontaneous cerebrospinal fluid rhinorrhea: a clinical and anatomical study. Laryngoscope (2010) 0.94
Correlation of the Epworth Sleepiness Scale with respiratory sleep parameters in patients with sleep-related breathing disorders and upper airway pathology. Eur Arch Otorhinolaryngol (2010) 0.94
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol (2013) 0.90
Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss. Otol Neurotol (2005) 0.90
Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential. Int J Cancer (2007) 0.88
Localization of congenital tegmen tympani defects. Otol Neurotol (2007) 0.87
Long-term results after interval therapy with intratympanic gentamicin for Menière's disease. Laryngoscope (2004) 0.86
Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report. Head Neck (2008) 0.85
Cerebrospinal fluid leaks of temporal bone origin: etiology and management. ORL J Otorhinolaryngol Relat Spec (2005) 0.84
DPOAE-grams in patients with acute tonal tinnitus. Otolaryngol Head Neck Surg (2005) 0.83
Fast alterations of vascular endothelial growth factor (VEGF) expression and that of its receptors (Flt-1, Flk-1 and Neuropilin) in the cochlea of guinea pigs after moderate noise exposure. Eur Arch Otorhinolaryngol (2006) 0.83
Akt and c-Jun N-terminal kinase are regulated in response to moderate noise exposure in the cochlea of guinea pigs. ORL J Otorhinolaryngol Relat Spec (2007) 0.82
Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Otol Neurotol (2011) 0.82
Endothelial nitric oxide synthase upregulation in the guinea pig organ of Corti after acute noise trauma. Brain Res (2005) 0.82
Long-term functional outcome after unilateral cordectomy. ORL J Otorhinolaryngol Relat Spec (2010) 0.82
Post-operative complications after removal of sporadic vestibular schwannoma via retrosigmoid-suboccipital approach: current diagnosis and management. Eur Arch Otorhinolaryngol (2011) 0.81
Association between surgical steps and intraoperative auditory brainstem response and electrocochleography waveforms during hearing preservation vestibular schwannoma surgery. Eur Arch Otorhinolaryngol (2008) 0.81
Vestibular function after acoustic neuroma removal with preservation of one branch of the vestibular nerve. Otol Neurotol (2002) 0.77
Quantitative analysis of VEGF-isoforms in head and neck squamous cell carcinoma cell lines: relation to xenotransplantability and tumour progression in mice. Oncol Rep (2002) 0.77
Localization of the two constitutively expressed nitric oxide synthase isoforms (nNOS and eNOS) in the same cell types in the saccule maculae of the frog Rana pipiens by immunoelectron microscopy: evidence for a back-up system? J Electron Microsc (Tokyo) (2003) 0.77
Acute effects of 1,1,1-trichloroethane on human olfactory functioning. Am J Rhinol (2004) 0.77
MGMT activity in mucosal epithelium and squamous cell carcinoma of the head and neck. Anticancer Res (2010) 0.76
Comparison of electronystagmography results with dynamic posturography findings in patients with vestibular schwannoma. Acta Otolaryngol (2007) 0.76
Evidence for a possible NOS back-up system in the organ of Corti of the guinea pig. Eur Arch Otorhinolaryngol (2003) 0.75
Influence of nerve of origin and tumor size of vestibular schwannoma on dynamic posturography findings. Acta Otolaryngol (2006) 0.75
Transient evoked otoacoustic emissions in vestibular neuritis. Ann Otol Rhinol Laryngol (2006) 0.75
Dynamic posturography findings predict balance status in vestibular schwannoma patients. Otol Neurotol (2007) 0.75
Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma. ORL J Otorhinolaryngol Relat Spec (2004) 0.75
Steroid and vasoactive treatment for acute deafness after attempted hearing preservation acoustic neuroma surgery. ORL J Otorhinolaryngol Relat Spec (2005) 0.75
Treatment for adult idiopathic and Wegener-associated subglottic stenosis. Eur Arch Otorhinolaryngol (2012) 0.75
Cochlear implantation after surgery for bilateral jugular foramen paragangliomas: a case report. Eur Arch Otorhinolaryngol (2008) 0.75
Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma. Acta Otolaryngol (2007) 0.75
Role of the host microenvironment on the expression of VEGF-subtypes in squamous cell carcinoma. Oncol Rep (2003) 0.75
The MED-EL SONATATI 100 cochlear implant: an evaluation of its safety in adults and children. Acta Otolaryngol (2011) 0.75
Effectiveness of oral zinc supplementation in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL). J Med Assoc Thai (2015) 0.75